A new genetic mutation that appears to protect people from developing Type 2 diabetes has been identified by an international team of researchers. The finding could lead to the development of new drug therapies to treat about 26 million Type 2 diabetics in the United States who rely on insulin and oral medication to manage the life-threatening disease for which there is no cure.